X

VFF

Supreme Cannabis (Fire) Withdraws Guidance – More Cost Cutting Needed

Legal cannabis producer Supreme Cannabis (TSE:FIRE) reported dissapointing results. Revenue came in at C$9 million, 10% worse than consensus of…

Aphria (APHA) Earnings – Guidance Cut But Still the Best Game in Town

Aphria (TSE: APHA; NYSE: APHA) earnings showed it has the cash to weather the coming storm and the profitability to…

HEXO About to Learn What it Means to Sink or Swim After Scary Earnings Report

Bottom Line After digging through the earnings of HEXO it's clear this company is not in a good place. Here…

Aphria Building a Gold Plated Balance Sheet With New $80 Million Financing

Bottom Line: Aphria has truly been the cannabis turnaround story of the last twelve months. This time last year investors…

Canadian Cannabis Scorecard (Summer 2019)

What is the Cannabis Scorecard? The Cannabis Scorecard is a comprehensive tool for investors to judge which Canadian companies are…

The Gimme 20% Return – Aphria Extraction Hack Explained

Aphria (TSE: APHA) has an undervalued asset hiding in Leamington Ontario that could lead to an immediate 20% jump in…

Aurora Cannabis Q3 2019 Earnings Review – Holding Pattern Continues

Aurora (TSX: ACB) reported Q3 earnings and showed growth in revenue, gross profit while decreasing costs. However, concerns remain with…

Aphria Q3 2019 Earnings Review – Headlines Create Opportunity

Aphria (TSE: APHA) posted messy quarterly results but remains an undervalued name with big revenue potential later in 2019.

Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want

Organigram (CVE: OGI) posted another strong quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.